Overview of antiretroviral treatment in China: advancement and challenges.
- Author:
Ling LUO
1
;
Tai-Sheng LI
Author Information
1. Department of Infectious Diseases, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Anti-Retroviral Agents;
adverse effects;
therapeutic use;
China;
epidemiology;
HIV Infections;
drug therapy;
epidemiology;
Humans;
Lipodystrophy;
chemically induced
- From:
Chinese Medical Journal
2011;124(3):440-444
- CountryChina
- Language:English
-
Abstract:
As the severity of the HIV epidemic in China grew, National Free Antiretroviral Treatment (ART) Program was announced since 2003. Even though there still were many difficulties, China had obtained great achievements in fighting against HIV. Over 52 000 adult patients had received first-line HAART thus far and the mortality of AIDS in China decreased significantly. This paper presents an overview of the HIV/AIDS epidemic in China; the status of national free ART program, the difficulties suffered and the achievements made since the initiation of program and the challenges ahead for continued progress for China. This paper also provides suggestions to overcome these challenges.
